Oncotarget

March 15, 2014

View Archive »

About The Cover

Corelation between EGFR endocytosis and gefitinib response in lung cancer cells with wtEGFR. See Jo et al.

Table of Contents

Editorial Materials

Dopamine signaling: target in glioblastoma

Dopamine signaling: target in glioblastoma

https://doi.org/10.18632/oncotarget.1835

Jiri Bartek,  and Zdenek Hodny
1116-1117
PDF  |  How to cite

Reviews

AID-induced remodeling of immunoglobulin genes and B cell fate

AID-induced remodeling of immunoglobulin genes and B cell fate

https://doi.org/10.18632/oncotarget.1546

Brice Laffleur, Nicolas Denis-Lagache, Sophie Péron, Christophe Sirac, Jeanne Moreau,  and Michel Cogné
1118-1131
Abstract  |  PDF  |  HTML  |  How to cite

Heat shock proteins in multiple myeloma

Heat shock proteins in multiple myeloma

https://doi.org/10.18632/oncotarget.1584

Lei Zhang, Jacqueline H.L. Fok,  and Faith E. Davies
1132-1148
Abstract  |  PDF  |  HTML  |  How to cite

Research Perspectives

Dissecting the p53-Mdm2 feedback loop in vivo: uncoupling the role in p53 stability and activity

Dissecting the p53-Mdm2 feedback loop in vivo: uncoupling the role in p53 stability and activity

https://doi.org/10.18632/oncotarget.1797

Vinod Pant,  and Guillermina Lozano
1149-1156
Abstract  |  PDF  |  HTML  |  How to cite

Latest progress in tyrosine kinase inhibitors

Latest progress in tyrosine kinase inhibitors

https://doi.org/10.18632/oncotarget.1836

Tatiana V. Pospelova,  and Valery A. Pospelov
1157-1161
Abstract  |  PDF  |  HTML  |  How to cite

Priority Research Papers

Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis

Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis

https://doi.org/10.18632/oncotarget.1699

Regina M. Graham, John W. Thompson,  and Keith A. Webster
1162-1173
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers

microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers

https://doi.org/10.18632/oncotarget.1682

Pierluigi Gasparini, Luciano Cascione, Matteo Fassan, Francesca Lovat, Gulnur Guler, Serdar Balci, Cigdem Irkkan, Carl Morrison, Carlo M. Croce, Charles L. Shapiro,  and Kay Huebner
1174-1184
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner

Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner

https://doi.org/10.18632/oncotarget.1803

Joshua Armenia, Linda Fabris, Francesca Lovat, Stefania Berton, Ilenia Segatto, Sara D’Andrea, Cristina Ivan, Luciano Cascione, George A. Calin, Carlo M. Croce, Alfonso Colombatti, Andrea Vecchione, Barbara Belletti,  and Gustavo Baldassarre
1185-1197
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia

https://doi.org/10.18632/oncotarget.1805

Sabine Cerny-Reiterer, Renata A. Meyer, Harald Herrmann, Barbara Peter, Karoline V. Gleixner, Gabriele Stefanzl, Emir Hadzijusufovic, Winfried F. Pickl, Wolfgang R. Sperr, Junia V. Melo, Hiroshi Maeda, Ulrich Jäger,  and Peter Valent
1198-1211
Abstract  |  PDF  |  HTML  |  How to cite

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.

https://doi.org/10.18632/oncotarget.1831

Vamsi K. Kolukula, Geetaram Sahu, Anton Wellstein, Olga C. Rodriguez, Anju Preet, Vito Iacobazzi, Gabriella D'Orazi, Chris Albanese, Ferdinando Palmieri,  and Maria Laura Avantaggiati
1212-1225
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

KIAA1114, a full-length protein encoded by the trophinin gene, is a novel surface marker for isolating tumor-initiating cells of multiple hepatocellular carcinoma subtypes

KIAA1114, a full-length protein encoded by the trophinin gene, is a novel surface marker for isolating tumor-initiating cells of multiple hepatocellular carcinoma subtypes

https://doi.org/10.18632/oncotarget.1677

Sae Won Kim, Hyun Gul Yang, Moon Cheol Kang, Seungwon Lee, Hong Namkoong, Seung-Woo Lee,  and Young Chul Sung
1226-1240
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

Research Papers

COX-2 overexpression increases malignant potential of human glioma cells through Id1

COX-2 overexpression increases malignant potential of human glioma cells through Id1

https://doi.org/10.18632/oncotarget.1370

Kaiming Xu, Lanfang Wang,  and Hui-Kuo G. Shu
1241-1252
Abstract  |  PDF  |  HTML  |  How to cite

Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells

Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells

https://doi.org/10.18632/oncotarget.1690

Tania Fontanil, Susana Rua, Maria Llamazares, Angela Moncada-Pazos, Pedro M. Quiros, Olivia Garcia-Suarez, Jose A. Vega, Takako Sasaki, Yamina Mohamedi, Manuel M. Esteban, Alvaro J. Obaya,  and Santiago Cal
1253-1264
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR

EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR

https://doi.org/10.18632/oncotarget.1711

Ukhyun Jo, Kyong Hwa Park, Young Mi Whang, Jae Sook Sung, Nam Hee Won, Jong Kuk Park,  and Yeul Hong Kim
1265-1278
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

p63 transcriptionally regulates the expression of matrix metallopeptidase 13

p63 transcriptionally regulates the expression of matrix metallopeptidase 13

https://doi.org/10.18632/oncotarget.1778

Ivana Celardo, Alexey Antonov, Ivano Amelio, Margherita Annicchiarico-Petruzzelli,  and Gerry Melino
1279-1289
Abstract  |  PDF  |  HTML  |  How to cite

Arsenic-induced sub-lethal stress reprograms human bronchial epithelial cells to CD61¯ cancer stem cells

Arsenic-induced sub-lethal stress reprograms human bronchial epithelial cells to CD61¯ cancer stem cells

https://doi.org/10.18632/oncotarget.1789

Qingshan Chang, Bailing Chen, Chitra Thakur, Yongju Lu,  and Fei Chen
1290-1303
Abstract  |  PDF  |  HTML  |  How to cite

Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition

Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition

https://doi.org/10.18632/oncotarget.1798

Qiong Wang, Shaoqing Shi, Weiyang He, Mabel T. Padilla, Lin Zhang, Xia Wang, Bin Zhang,  and Yong Lin
1304-1314
Abstract  |  PDF  |  HTML  |  How to cite

Epigenetic repression of phosphatidylethanolamine N-methyltransferase (PEMT) in BRCA1-mutated breast cancer

Epigenetic repression of phosphatidylethanolamine N-methyltransferase (PEMT) in BRCA1-mutated breast cancer

https://doi.org/10.18632/oncotarget.1800

Da Li, Fang-Fang Bi, Na-Na Chen, Ji-Min Cao, Wu-Ping Sun, Yi-Ming Zhou, Chen Cao, Chun-Yan Li,  and Qing Yang
1315-1325
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

Basal level of FANCD2 monoubiquitination is required for the maintenance of a sufficient number of licensed-replication origins to fire at a normal rate

Basal level of FANCD2 monoubiquitination is required for the maintenance of a sufficient number of licensed-replication origins to fire at a normal rate

https://doi.org/10.18632/oncotarget.1796

Jayabal Panneerselvam, Anna Pickering, Bing Han, Liantao Li, Junnian Zheng, Jun Zhang, Yanbin Zhang,  and Peiwen Fei
1326-1337
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme

MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme

https://doi.org/10.18632/oncotarget.1793

Kristina H. Knubel, Ben M. Pernu, Alexandra Sufit, Sarah Nelson, Angela M. Pierce,  and Amy K. Keating
1338-1351
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis

Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis

https://doi.org/10.18632/oncotarget.1817

Xi Tang, Sumit S. Mahajan, Liem T. Nguyen, François Béliveau, Richard Leduc, Julian A. Simon,  and Valeri Vasioukhin
1352-1362
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

Targeting Aerobic Glycolysis and HIF-1α Expression Enhance Imiquimod-induced Apoptosis in Cancer Cells

Targeting Aerobic Glycolysis and HIF-1α Expression Enhance Imiquimod-induced Apoptosis in Cancer Cells

https://doi.org/10.18632/oncotarget.1734

Shi-Wei Huang, Jun-Kai Kao, Chun-Ying Wu, Sin-Ting Wang, Hsin-Chen Lee, Shu-Mei Liang, Yi-Ju Chen,  and Jeng-Jer Shieh
1363-1381
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane

Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane

https://doi.org/10.18632/oncotarget.1837

Olga V. Glinskii, Feng Li, Landon S. Wilson, Stephen Barnes, Kate Rittenhouse-Olson, Joseph J. Barchi Jr, Kenneth J. Pienta,  and Vladislav V. Glinsky
1382-1389
Abstract  |  PDF  |  HTML  |  How to cite


Copyright © 2024 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC